Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic Acid 6-sodium Salt
2. 12-sulfodehydroabietic Acid
3. Ecabet
4. Ta 2711
5. Ta-2711
6. Ta-2711e
1. 86408-72-2
2. Ecabet Sodium Salt
3. Ta-2711
4. Sulfodehydroabietic Acid Monosodium Salt
5. 51mo2b2osb
6. Ta-2711e
7. Gastrom
8. Ecabet Sodium [jan]
9. Unii-51mo2b2osb
10. Ecabet (sodium Salt)
11. Ecabet Monosodium
12. 12-sulfodehydroabietic Acid Monosodium Salt
13. Mls006010228
14. Ecabet Sodium [mart.]
15. Schembl1650174
16. Ecabet Sodium Salt [mi]
17. Ecabet Monosodium [who-dd]
18. Amy18112
19. Bcp11708
20. Mfcd00866896
21. Akos022171692
22. Ccg-268671
23. Smr004701309
24. E1224
25. Q27260913
26. 1-phenanthrenecarboxylic Acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-, (1r-(1-alpha,4a-beta,10a-alpha))-, Monosodium Salt
27. 1-phenanthrenecarboxylic Acid, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-6-sulfo-, Monosodium Salt, (1r,4as,10ar)-
28. Sodium (4bs,8r,8ar)-8-carboxy-2-isopropyl-4b,8-dimethyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-3-sulfonate
29. Sodium (4bs,8r,8ar)-8-carboxy-4b,8-dimethyl-2-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthrene-3-sulfonate
Molecular Weight | 402.5 g/mol |
---|---|
Molecular Formula | C20H27NaO5S |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 402.14768941 g/mol |
Monoisotopic Mass | 402.14768941 g/mol |
Topological Polar Surface Area | 103 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 672 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
Protease Inhibitors
Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Ecabet Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ecabet Sodium, including repackagers and relabelers. The FDA regulates Ecabet Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ecabet Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ecabet Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ecabet Sodium supplier is an individual or a company that provides Ecabet Sodium active pharmaceutical ingredient (API) or Ecabet Sodium finished formulations upon request. The Ecabet Sodium suppliers may include Ecabet Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Ecabet Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ecabet Sodium DMF (Drug Master File) is a document detailing the whole manufacturing process of Ecabet Sodium active pharmaceutical ingredient (API) in detail. Different forms of Ecabet Sodium DMFs exist exist since differing nations have different regulations, such as Ecabet Sodium USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ecabet Sodium DMF submitted to regulatory agencies in the US is known as a USDMF. Ecabet Sodium USDMF includes data on Ecabet Sodium's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ecabet Sodium USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ecabet Sodium suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ecabet Sodium Drug Master File in Japan (Ecabet Sodium JDMF) empowers Ecabet Sodium API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ecabet Sodium JDMF during the approval evaluation for pharmaceutical products. At the time of Ecabet Sodium JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ecabet Sodium suppliers with JDMF on PharmaCompass.
Ecabet Sodium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ecabet Sodium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ecabet Sodium GMP manufacturer or Ecabet Sodium GMP API supplier for your needs.
A Ecabet Sodium CoA (Certificate of Analysis) is a formal document that attests to Ecabet Sodium's compliance with Ecabet Sodium specifications and serves as a tool for batch-level quality control.
Ecabet Sodium CoA mostly includes findings from lab analyses of a specific batch. For each Ecabet Sodium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ecabet Sodium may be tested according to a variety of international standards, such as European Pharmacopoeia (Ecabet Sodium EP), Ecabet Sodium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ecabet Sodium USP).
LOOKING FOR A SUPPLIER?